The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Open accessAbstract
Fas/APO-1 is a transmembrane protein of the nerve growth factor/TNF alpha receptor family which signals apoptotic cell death in susceptible target cells. We have investigated the susceptibility of seven human malignant glioma cell lines to Fas/APO-1-dependent apoptosis. Sensitivity to Fas/APO-1 antibody-mediated cell killing correlated with cell surface expression of Fas/APO-1. Expression of Fas/APO-1 as well as Fas/APO-1-dependent cytotoxicity were augmented by preexposure of human malignant glioma cells to IFN gamma and TNF alpha. Further, pretreatment with TGF beta 2, IL1 and IL8 enhanced Fas/APO-1 antibody-induced glioma cell apoptosis whereas other cytokines including TNF beta, IL6, macrophage colony-stimulating factor, IL10 and IL13 had no such effect. None of the human malignant glioma cell lines was susceptible to TNF alpha-induced cytotoxicity. Fas/APO-1 antibody-sensitive glioma cell lines (n = 5), but not Fas/APO-1 antibody-resistant glioma cell lines (n = 2), became sensitive to TNF alpha when co-treated with inhibitors of RNA and protein synthesis. Resistance of human glioma cells to Fas/APO-1 antibody-mediated apoptosis was mainly related to low level expression of Fas/APO-1 and appeared not to be linked to overexpression of the anti-apoptotic protooncogene, bcl-2. Given the resistance of human malignant glioma to surgery, irradiation, chemotherapy and immunotherapy, we propose that Fas/APO-1 may be a promising target for a novel locoregionary approach to human malignant glioma. This strategy gains support from the demonstration of Fas/APO-1 expression in ex vivo human malignant glioma specimens and from the absence of Fas/APO-1 in normal human brain parenchyma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Bcl-2 and the regulation of programmed cell death
Reed, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.1 · Cited by 2,305
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Self-citationChen, Y., & Wu, H. (2010) · Chinese Science Bulletin · doi:10.1007/s11434-010-3275-4 · Cited by 1,594
Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,288
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
Apoptosis: The Biochemistry and Molecular Biology of Programmed Cell Death*
SCHWARTZMAN, R. A., & CIDLOWSKI, J. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-133 · Cited by 1,040
Cohen, J. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90214-6 · Cited by 987
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 839
Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., & Trauth, B. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50076-x · Cited by 834
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1274 · Cited by 815
Wong, G. H. W., Elwell, J. H., Oberley, L. W., & Goeddel, D. V. (1989) · Cell · doi:10.1016/0092-8674(89)90944-6 · Cited by 802
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
Astrocytes present myelin basic protein to encephalitogenic T-cell lines
Fontana, A., Fierz, W., & Wekerle, H. (1984) · Nature · doi:10.1038/307273a0 · Cited by 771
Self-citationAntigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells
Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel, C., & Fontana, A. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170909 · Cited by 642
Self-citationLeithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., & Möller, P. (1993) · PubMed · Cited by 625
Self-citationCytotoxic mechanism of tumor necrosis factor‐α
Larrick, J. W., & Wright, S. C. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.14.2172061 · Cited by 531
Fas transduces activation signals in normal human T lymphocytes.
Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., & Lynch, D. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2231 · Cited by 521
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., & Taniguchi, N. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3753 · Cited by 494
Activation interferes with the APO-1 pathway in mature human T cells
Klas, C., Debatin, K.-M., Jonker, R. R., & Krammer, P. H. (1993) · International Immunology · doi:10.1093/intimm/5.6.625 · Cited by 447
Self-citationEffect of bcl-2 on Fas antigen-mediated cell death.
Itoh, N., Tsujimoto, Y., & Nagata, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.621 · Cited by 428
Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid, I., & Fontana, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3222 · Cited by 386
Self-citationProgrammed cell death, apoptosis and killer genes
Schwartz, L. M., & Osborne, B. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90197-s · Cited by 385
Constam, D. B., Philipp, J., Malipiero, U. V., ten Dijke, P., Schachner, M., & Fontana, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.5.1404 · Cited by 373
Self-citationGlioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.
Fontana, A., Hengartner, H., de Tribolet, N., & Weber, E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.1837 · Cited by 366
Self-citationDhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Möller, P., & Krammer, P. H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3166 · Cited by 278
Self-citationApoptosis Biochemical events and relevance to cancer chemotherapy
Sen, S., & D'Incalci, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80914-3 · Cited by 236
Shi, Y. F., Szalay, M. G., Paskar, L., Sahai, B. M., Boyer, M., Singh, B., & Green, D. R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3326 · Cited by 195
Mapara, M. Y., Bargou, R., Zugck, C., Döhner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H., & Dörken, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230320 · Cited by 169
Self-citationVaux, D. L., Aguila, H. L., & Weissman, I. L. (1992) · International Immunology · doi:10.1093/intimm/4.7.821 · Cited by 164
Bcl-2: an antidote to programmed cell death.
Korsmeyer, S. J. (1992) · PubMed · Cited by 152
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.
Meir, E. G. V., Ceska, M., Effenberger, F., Walz, A., Grouzmann, E., Desbaillets, I., Frei, K., Fontana, A., & de Tribolet, N. (1992) · PubMed · Cited by 151
Self-citationWeller, M., Constam, D. B., Malipiero, U., & Fontana, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240608 · Cited by 113
Self-citationMaxwell, M., Galanopoulos, T., Neville-Golden, J., & Antoniades, H. N. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.76.5.0799 · Cited by 107
Vanhaesebroeck, B., Reed, J. C., VALCK, D. D., et al. (1993) · PubMed · Cited by 106
Moller, P., Henne, C., Leithäuser, F., Eichelmann, A., Schmidt, A., Brüderlein, S., Dhein, J., & Krammer, P. (1993) · Blood · doi:10.1182/blood.v81.8.2067.2067 · Cited by 98
Self-citationFalk, M., Trauth, B. C., Debatin, K., Klas, C., Gregory, C., Rickinson, A. B., Calender, A., Lenoir, G., Ellwart, J., & Krammer, P. (1992) · Blood · doi:10.1182/blood.v79.12.3300.bloodjournal79123300 · Cited by 96
Self-citationInflammatory leukocytes associated with increased immunosuppression by glioblastoma
Black, K. L., Chen, K., Becker, D. P., & Merrill, J. E. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.77.1.0120 · Cited by 85
Cytokines and immunoregulatory molecules in malignant glial neoplasms
Schneider, J., Hofman, F. M., Apuzzo, M. L. J., & Hinton, D. R. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.77.2.0265 · Cited by 80
Differential expression of APO‐1 on human thymocytes: Implications for negative selection?
Debatin, K., Süss, D., & Krammer, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240339 · Cited by 63
Self-citationRuffini, P. A., Rivoltini, L., Silvani, A., Boiardi, A., & Parmiani, G. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01742258 · Cited by 61
Frei, K., Piani, D., Malipiero, U., Meir, E. G. V., de Tribolet, N., & Fontana, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3140 · Cited by 58
Self-citationDeen, D. F., Chiarodo, A., Grimm, E. A., Fike, J. R., Israel, M. A., Kun, L. E., Levin, V. A., Marton, L. J., Packer, R. J., Pegg, A. E., et al. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01057041 · Cited by 55
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis???
McCarty, L. (1990) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199005000-00002 · Cited by 42
Distribution of transforming growth factor-β1 in human astrocytomas
Horst, H.-A., Scheithauer, B. W., Kelly, P. J., & Kovach, J. S. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90297-g · Cited by 33
Tada, M., Sawamura, Y., Sakuma, S., Suzuki, K., Ohta, H., Aida, T., & Abe, H. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01740907 · Cited by 32
Tada, T., Yabu, K., & Kobayashi, S. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00174.x · Cited by 29
Cited by
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
“First, various human glioma cell lines and primary glioma-derived cell cultures are sensitive to death ligand-mediated apoptosis in vitro and in xenograft model systems in vivo (Weller et al. 1994; Roth et al. 1997; Shinoura et al. 1998; Nagane et al. 2000; Maleniak et al. 2001; Rohn et al. 2001).”
BackgroundThe Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1075 · Cited by 878
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V, Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119273 · Cited by 398
Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
D'Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., Raine, C. S., & Antel, J. P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2361 · Cited by 354
A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A., & Weller, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4772 · Cited by 325
Self-citation
Metadata
- Authors
- Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., & Fontana, A.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-09-01
- Volume
- 94
- Issue
- 3
- Pages
- 954-964
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2166487006
- Cited by
- 345
- References
- 57
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.